AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19660039 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic information based on 4-week wound characteristics
Number of subjects: 0
Study 19660039 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic information based on 4-week characteristics for diabetic neuropathic foot ulcers
Number of subjects: 0
Study 19660039 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prognostic information)
Number of subjects: 0
Study 16504633 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor (4 microg/kg per minute)
Number of subjects: 399
Study 16504633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 16504633 — intervention group
Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 399
Study 14705155 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorexia nervosa treatment study
Number of subjects: 0
Study 14705155 — intervention group
Group type: COMPARATOR
Intervention: Bulimia nervosa studies
Number of subjects: 0
Study 11194932 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin suppression test modified with octreotide
Number of subjects: 45
Study 11194932 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 45
Study 9315153 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal sonohysterography
Number of subjects: 29
Study 9315153 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal sonography
Number of subjects: 29
Study 9315153 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 29
Study 9315153 — intervention group
Group type: COMPARATOR
Intervention: Curettage
Number of subjects: 29
Study 8325299 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (5 mg)
Number of subjects: 10
Study 8325299 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (500 micrograms)
Number of subjects: 10
Study 8325299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3098417 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour iv infusion of recombinant interferon-gamma (rIFN-gamma) at doses ranging from 0.016 to 0.65 mg/m2/day
Number of subjects: 62
Study 3098417 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour iv infusion of recombinant interferon-gamma (rIFN-gamma) at doses ranging from 0.01 to 0.05 mg/m2/day
Number of subjects: 62
Study 30055991 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane (ESP) block with 3 mg/kg of 0.375% ropivacaine before anesthesia induction
Number of subjects: 106
Study 30055991 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (1 gm every 6 hours) and tramadol (50 mg every 8 hours) intravenously
Number of subjects: 106
Study 30527177 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib 80 mg once daily
Number of subjects: 820
Study 30527177 — intervention group
Group type: COMPARATOR
Intervention: Platinum-pemetrexed (intravenous every 3 weeks for up to six cycles)
Number of subjects: 820
Study 30527177 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 820
Study 30527177 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare EGFR mutations
Number of subjects: 820
Study 27150079 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam administration (7-8 days)
Number of subjects: 36
Study 25082564 — intervention group
Group type: EXPERIMENTAL
Intervention: pemetrexed 500mg/m2 + cisplatin 75mg/m2 (PC)
Number of subjects: 256
Study 25082564 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine 1250mg/m2 + cisplatin 75mg/m2 (GC)
Number of subjects: 256
Study 25082564 — intervention group
Group type: EXPERIMENTAL
Intervention: pemetrexed/cisplatin (PC)
Number of subjects: 256
Study 25082564 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine/cisplatin (GC)
Number of subjects: 256
Study 22386799 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Goals Collaborative Care (LGCC)
Number of subjects: 134
Study 22386799 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 134
Study 20595307 — intervention group
Group type: EXPERIMENTAL
Intervention: ITPA tool
Number of subjects: 145
Study 20595307 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study 17803897 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 16121971 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 million implanted cells
Number of subjects: 18
Study 16121971 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 million implanted cells
Number of subjects: 18
Study 16121971 — intervention group
Group type: COMPARATOR
Intervention: Control group (rehabilitation only)
Number of subjects: 18
Study 16121971 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Research Arm Test
Number of subjects: 18
Study 16121971 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke Impact Scale
Number of subjects: 18
Study 16121971 — intervention group
Group type: EXPERIMENTAL
Intervention: Everyday Memory test
Number of subjects: 18
Study 11688103 — intervention group
Group type: EXPERIMENTAL
Intervention: New method (N)
Number of subjects: 84
Study 11688103 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (T)
Number of subjects: 84
Study 9529807 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded amalgam sealants
Number of subjects: 0
Study 9529807 — intervention group
Group type: COMPARATOR
Intervention: Resin-based pit and fissure sealants
Number of subjects: 0
Study 7848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous nitroglycerin infusion for the first 48 hours after acute MI
Number of subjects: 0
Study 7848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged therapy with nitrates spanning the healing phase of acute anterior Q-wave MI
Number of subjects: 0
Study 7848898 — intervention group
Group type: COMPARATOR
Intervention: Long-term nitrate therapy in patients with suspected MI
Number of subjects: 0
Study 3396474 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose cefotaxime (1g)
Number of subjects: 1950
Study 29794563 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous sciatic nerve blockade with 5 ml/h ropivacaine 0.2% (CO)
Number of subjects: 50
Study 29794563 — intervention group
Group type: COMPARATOR
Intervention: Single injection sciatic nerve blockade with 5 ml/h saline infusion (SIN)
Number of subjects: 50
Study 29794563 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous sciatic nerve blockade (CO)
Number of subjects: 50
Study 29794563 — intervention group
Group type: COMPARATOR
Intervention: Single injection sciatic nerve blockade (SIN)
Number of subjects: 50
Study 29794563 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 26568249 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSE) 300 mg/d (150 mg twice daily) for 6 weeks
Number of subjects: 36
Study 26568249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg GSE) for 6 weeks
Number of subjects: 36
Study 25870665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal administration of triamcinolone acetonide
Number of subjects: 0
Study 25870665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal administration of triamcinolone acetonide in combination with bevacizumab
Number of subjects: 0
Study 22445441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (10mg/day)
Number of subjects: 63
Study 22445441 — intervention group
Group type: COMPARATOR
Intervention: Doubling of statin dose
Number of subjects: 63
Study 20491720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for psychosis (CBTp)
Number of subjects: 74
Study 20491720 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 74
Study 18949295 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + saline
Number of subjects: 15
Study 18949295 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + 2% chlorhexidine gluconate (CHX) gel
Number of subjects: 15
Study 18949295 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study 16181937 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation intervention
Number of subjects: 131
Study 16181937 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization exercise intervention
Number of subjects: 131
Study 12182236 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg orally)
Number of subjects: 10
Study 12182236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12182236 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 10
Study 11009276 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 150
Study 11009276 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 150
Study 8776184 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion without heparin-bonded circuit (Group 2)
Number of subjects: 105
Study 8776184 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion with heparin-bonded circuit (Group 3)
Number of subjects: 105
Study 8776184 — intervention group
Group type: COMPARATOR
Intervention: No autotransfusion (Group 1)
Number of subjects: 105
Study 1632172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vf of 50 ml.kg‐1.min‐1 (Group 1)
Number of subjects: 46
Study 1632172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vf of 75 ml.kg‐1.min‐1 (Group 2)
Number of subjects: 46
Study 1632172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vf of 100 ml.kg‐1.min‐1 (Group 3)
Number of subjects: 46
Study 1632172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vf of 100 ml.kg‐1.min‐1 for 15 min, 75 ml.kg‐1.min‐1 for the next 15 min and 50 ml.kg‐1.min‐1 thereafter (Group 4)
Number of subjects: 46
Study 1632172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vf of 25 ml.kg‐1.min‐1 for 10 min and switched off for the remainder of the procedure (Group 5)
Number of subjects: 46
Study 6432173 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral subcutaneous sphincterotomy
Number of subjects: 58
Study 6432173 — intervention group
Group type: COMPARATOR
Intervention: Anal dilatation
Number of subjects: 58
Study 31764105 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV-based ART
Number of subjects: 720
Study 31764105 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF-based ART
Number of subjects: 720
Study 31764105 — intervention group
Group type: COMPARATOR
Intervention: ZDV alone
Number of subjects: 720
Study 29684771 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation at a daily dose of 30 mg for 100 days
Number of subjects: 90
Study 29684771 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation at a daily dose of 60 mg for 100 days
Number of subjects: 90
Study 26590366 — intervention group
Group type: EXPERIMENTAL
Intervention: Export®
Number of subjects: 185
Study 26590366 — intervention group
Group type: COMPARATOR
Intervention: Angiojet®
Number of subjects: 185
Study 24290594 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast hydrolysate 1 g/d
Number of subjects: 0
Study 24290594 — intervention group
Group type: COMPARATOR
Intervention: Placebo 1 g/d
Number of subjects: 0
Study 23238142 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cycles of AC regimen followed by three cycles of Paclitaxel
Number of subjects: 50
Study 23238142 — intervention group
Group type: COMPARATOR
Intervention: Six cycles of AC regimen
Number of subjects: 50
Study 20850091 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intracoronary delivery of abciximab through a dedicated perfusion catheter
Number of subjects: 50
Study 20850091 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary infusion of abciximab through the guiding catheter
Number of subjects: 50
Study 20850091 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intracoronary delivery of abciximab
Number of subjects: 50
Study 20850091 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary infusion of abciximab
Number of subjects: 50
Study 17620527 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 6315
Study 17620527 — intervention group
Group type: COMPARATOR
Intervention: Fibrinolysis
Number of subjects: 6315
Study 15832331 — intervention group
Group type: EXPERIMENTAL
Intervention: Real magnetic field (MF) exposure
Number of subjects: 24
Study 15832331 — intervention group
Group type: COMPARATOR
Intervention: Sham magnetic field (MF) exposure
Number of subjects: 24
Study 15832331 — intervention group
Group type: COMPARATOR
Intervention: Real and sham EMF exposure
Number of subjects: 24
Study 12577328 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HACE and Chinese herbal medicine (Gan'ai No. I and No. II)
Number of subjects: 60
Study 12577328 — intervention group
Group type: COMPARATOR
Intervention: HACE alone
Number of subjects: 60
Study 9243959 — intervention group
Group type: EXPERIMENTAL
Intervention: Random feedback (success)
Number of subjects: 60
Study 9243959 — intervention group
Group type: EXPERIMENTAL
Intervention: Random feedback (failure)
Number of subjects: 60
Study 8500518 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 4
Study 8500518 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated subjects)
Number of subjects: 4
Study 3034690 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of LTB4
Number of subjects: 9
Study 3034690 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 12-HETE
Number of subjects: 9
Study 3034690 — intervention group
Group type: COMPARATOR
Intervention: Control lesions (not specified treatment)
Number of subjects: 9
Study 2543582 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural or synthetic retinoids (RA, acitretin, isotretinoin, Ro137410, retinol) applied daily for 4 days
Number of subjects: 0
Study 2543582 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dithranol treatment, UVB irradiation, or scotch tape stripping
Number of subjects: 0
Study 2543582 — intervention group
Group type: COMPARATOR
Intervention: Topical diflucortolone
Number of subjects: 0
Study 2543582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro150778 (no affinity and no reported transformation)
Number of subjects: 0
Study 31404053 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted technique (TINAVI)
Number of subjects: 696
Study 31404053 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted technique (Renaissance)
Number of subjects: 696
Study 31404053 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted techniques
Number of subjects: 696
Study 31404053 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 696
Study 31595867 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs)
Number of subjects: 0
Study 31595867 — intervention group
Group type: COMPARATOR
Intervention: Control households (no ITNs)
Number of subjects: 0
Study 28617848 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 9
Study 27337853 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum IUD insertion
Number of subjects: 28
Study 23983239 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PTEN expression
Number of subjects: 805
Study 23983239 — intervention group
Group type: EXPERIMENTAL
Intervention: PTEN and IGF-IR expression models
Number of subjects: 805
Study 23983239 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal level of IGF-IR expression
Number of subjects: 805
Study 21348213 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of ephedrine intravenously (EPHE‐5)
Number of subjects: 96
Study 21348213 — intervention group
Group type: COMPARATOR
Intervention: 10 mg of ephedrine intravenously (EPHE‐10)
Number of subjects: 96
Study 21348213 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mL of HES 130/0.4 in rapid infusion over 15 minutes
Number of subjects: 96
Study 19130635 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture treatment group
Number of subjects: 100
Study 19130635 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment group (control)
Number of subjects: 100
Study 16816926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene 30 mg
Number of subjects: 118
Study 16816926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg
Number of subjects: 118
Study 16816926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene 90 mg
Number of subjects: 118
Study 16816926 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene 60 mg
Number of subjects: 118
Study 15273435 — intervention group
Group type: EXPERIMENTAL
Intervention: Early carotid endarterectomy (CEA) within 24 hours
Number of subjects: 40
Study 15273435 — intervention group
Group type: COMPARATOR
Intervention: Delayed carotid endarterectomy (CEA) at 8 weeks
Number of subjects: 40
Study 11515884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g bolus before skin incision, followed by continuous infusion of 400 mg/hr during surgery)
Number of subjects: 40
Study 11515884 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 40
Study 9248987 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty
Number of subjects: 50
Study 9248987 — intervention group
Group type: COMPARATOR
Intervention: Gastric banding
Number of subjects: 50
Study 9248987 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study 8498877 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 54
Study 8498877 — intervention group
Group type: EXPERIMENTAL
Intervention: New psychopharmacologic treatments
Number of subjects: 54
Study 3101804 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 154
Study 3101804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 30945493 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group (deep needling of Lianquan (CV23) and Yifeng (TE17), conventional acupuncture of other acupoints, electroacupuncture stimulation)
Number of subjects: 104
Study 30945493 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional swallowing rehabilitation training)
Number of subjects: 104
Study 30945493 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 104
Study 30945493 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 28244407 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated IMRT (HIMRT) - 70.2 Gy in 26 fractions
Number of subjects: 303
Study 28244407 — intervention group
Group type: COMPARATOR
Intervention: Conventional IMRT (CIMRT) - 76 Gy in 38 fractions
Number of subjects: 303
Study 25680826 — intervention group
Group type: EXPERIMENTAL
Intervention: SFI + EGDT
Number of subjects: 45
Study 25680826 — intervention group
Group type: COMPARATOR
Intervention: EGDT
Number of subjects: 45
Study 23590271 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead space (DS) loading of 0.6 L during exercise
Number of subjects: 40
Study 23590271 — intervention group
Group type: COMPARATOR
Intervention: Unloaded control
Number of subjects: 40
Study 23590271 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead space (DS) loading of 0.6 L at 60 W
Number of subjects: 40
Study 21218306 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual motivational interviewing
Number of subjects: 256
Study 21218306 — intervention group
Group type: EXPERIMENTAL
Intervention: Group motivational interviewing
Number of subjects: 256
Study 21218306 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐led hepatitis health promotion
Number of subjects: 256
Study 21218306 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 256
Study 19221371 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug facts box in symptom drug box trial
Number of subjects: 450
Study 19221371 — intervention group
Group type: COMPARATOR
Intervention: Control group (actual drug ads) in symptom drug box trial
Number of subjects: 450
Study 19221371 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug facts box in prevention drug box trial
Number of subjects: 450
Study 19221371 — intervention group
Group type: COMPARATOR
Intervention: Control group (actual drug ads) in prevention drug box trial
Number of subjects: 450
Study 17143125 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT + C-MIS
Number of subjects: 385
Study 17143125 — intervention group
Group type: COMPARATOR
Intervention: NRT
Number of subjects: 385
Study 12547988 — intervention group
Group type: EXPERIMENTAL
Intervention: Japan's contribution to cardiovascular disease research
Number of subjects: 0
Study 12547988 — intervention group
Group type: COMPARATOR
Intervention: Randomized Controlled Trials (RCT)
Number of subjects: 0
Study 12547988 — intervention group
Group type: COMPARATOR
Intervention: Case-Control/Cohort Studies
Number of subjects: 0
Study 12547988 — intervention group
Group type: COMPARATOR
Intervention: Case Reports
Number of subjects: 0
Study 12547988 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall contribution
Number of subjects: 0
Study 11320598 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicenter clinical trials
Number of subjects: 20
Study 11320598 — intervention group
Group type: EXPERIMENTAL
Intervention: Careful planning and monitoring
Number of subjects: 20
Study 9426082 — intervention group
Group type: COMPARATOR
Intervention: Conventional jet nebulizer (Acorn)
Number of subjects: 18
Study 9426082 — intervention group
Group type: COMPARATOR
Intervention: Conventional jet nebulizer with storage chamber (Mizer)
Number of subjects: 18
Study 9426082 — intervention group
Group type: EXPERIMENTAL
Intervention: Venturi nebulizer (Ventstream)
Number of subjects: 18
Study 9426082 — intervention group
Group type: EXPERIMENTAL
Intervention: Venturi nebulizer (Pari LC)
Number of subjects: 18
Study 9426082 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Venturi nebulizers
Number of subjects: 18
Study 8513906 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen impregnated Dacron (Meadox Hemashield)
Number of subjects: 36
Study 8513906 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumen coated Dacron (USCI)
Number of subjects: 36
Study 8513906 — intervention group
Group type: COMPARATOR
Intervention: Standard knitted Dacron (Meadox Microvel, UCSI Vasculour II) preclotted with patient's own blood
Number of subjects: 36